Overview of Dr. Francis
Dr. Jasmine Francis is an ophthalmologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from New York University Grossman School of Medicine and has been in practice 10 years. She is one of 23 doctors at Memorial Sloan Kettering Cancer Center who specialize in Ophthalmology. She has more than 100 publications and over 500 citings.
Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021- Is this information wrong?
Education & Training
- Icahn School of Medicine at Mount Sinai/New York Eye and Ear Infirmary at Mount SinaiResidency, Ophthalmology, 2008 - 2011
- New York University School of MedicineClass of 2007
Certifications & Licensure
- NY State Medical License 2008 - 2024
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 199 citationsEfficacy of MEK inhibition in patients with histiocytic neoplasmsEli L. Diamond, Benjamin H. Durham, Gary A. Ulaner, Esther Drill, Justin Buthorn
Nature. 2019-03-01 - 4 citationsSuccessful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intra-arterial Chemotherapy (Ophthalmic Artery Chemosurgery).David H. Abramson, Y. Pierre Gobin, Ira J. Dunkel, Jasmine H. Francis
Ophthalmology. Retina. 2021-09-01 - 34 citationsTreatment of Retinoblastoma: What Is the Latest and What Is the Future.Paula Schaiquevich, Jasmine H Francis, María Belén Cancela, Angel Montero Carcaboso, Guillermo L Chantada
Frontiers in Oncology. 2022-01-01
Journal Articles
- Growth Patterns of Survivors of Retinoblastoma Treated with Ophthalmic Artery ChemosurgeryJasmine H Francis, Y Pierre Gobin, David H Abramson, PLoS One
- Total Retinal Detachments Due to Retinoblastoma: Outcomes Following Intra-Arterial chemotherapy/ophthalmic Artery ChemosurgeryIra J Dunkel, Jasmine H Francis, Y Pierre Gobin, Scott E Brodie, David H Abramson, PLoS One
- Clinical and Morphologic Characteristics of MEK Inhibitor–Associated RetinopathyJasmine Francis, MD, Ophthalmology
Press Mentions
- FDA Approves First Treatment for Patients with All Forms of HistiocytosisJanuary 30th, 2023
- Doctors Identify an Eye Cancer CulpritSeptember 13th, 2021
- Twenty-Year Collaboration Between North American and South American Retinoblastoma ProgramsMarch 30th, 2020
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: